Search for: "Boehringer Ingelheim GmbH" Results 21 - 40 of 51
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Feb 2014, 6:00 am by LTA-Editor
District Court Judge David Herndon from the Southern District of Illinois imposed close to $1 million in punitive damages on defendants Boehringer Ingelheim International GMBH (“BII”) and Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
28 Jan 2014, 11:53 am
  In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., and Boehringer Ingelheim Int’l. [read post]
2 May 2013, 10:30 am by Amanda Greenburg
On March 26, 2013, Plaintiff Lisa Mulhall filed a claim in the Illinois Southern District Court against the manufacturers of Pradaxa, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH, for causing her mother’s death. [read post]
31 Jan 2011, 8:10 am by Stefanie Levine
Terminal Disclaimers and Section 121 Boehringer Ingelheim International GmbH v. [read post]
31 Jan 2011, 8:10 am by Stefanie Levine
Terminal Disclaimers and Section 121 Boehringer Ingelheim International GmbH v. [read post]
9 Dec 2010, 3:53 am by Bob Kraft
" Specifically, "Boehringer Ingelheim GmbH's Roxane Inc. will pay $280 million, Abbott will pay $126.5 million and B. [read post]
9 Dec 2010, 2:49 am by Bob Kraft
” Specifically, “Boehringer Ingelheim GmbH’s Roxane Inc. will pay $280 million, Abbott will pay $126.5 million and B. [read post]
2 Nov 2010, 1:40 am
AstraZeneca sought and got a preliminary injunction against Apotex, which was hankering to launch a generic version of the asthma drug Pulmicort. [read post]
13 May 2010, 4:58 pm
(FDA Law Blog) US: Divisional of a divisional: Avoid terminal disclaimers: CAFC denies en banc rehearing in Boehringer Ingelheim International GMBH v. [read post]
13 May 2010, 4:44 pm by mcarzima@imediainc.com
  The companies, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Roxane Inc., Ben Venue Laboratories Inc. and Roxane Laboratories Inc., are all affiliates of German drug giant, Boehringer Ingelheim GmbH. [read post]
5 May 2010, 4:46 am
– Supreme Court of Justice decision on Viagra patent (IPKat) (IP tango) Further developments on double patenting at the EPO – T1423/07 Cyclic Amine derivative/BOEHRINGER INGELHEIM VETMEDICA GmbH (IPKat) (EPLAW)   General BIO announces new policy on options for increasing access to medicines in the developing world (Patently BIOtech) BIO2010 Day 1 & 2: Getting Settled & Meetings & Measuring Biotechnology Innovation  (Biotech Blog) (Biotech… [read post]
1 May 2010, 11:00 am by Oliver G. Randl
The present decision deals with the refusal of an application on the ground of unallowable double patenting. [read post]
10 Mar 2010, 5:22 am
(FDA Law Blog) US: Review and correction of patent term adjustment calculation made by the USPTO: Boehringer Ingelheim Pharma GmbH & Co. [read post]
10 Mar 2010, 5:22 am
(FDA Law Blog) US: Review and correction of patent term adjustment calculation made by the USPTO: Boehringer Ingelheim Pharma GmbH & Co. [read post]
30 Dec 2009, 3:44 am by gmlevine
In this event Panels partially dismiss complaints to the extent that they include additional unrelated respondents, as in Boehringer Ingelheim Pharma GmbH & Co. [read post]
25 Aug 2009, 1:30 pm
Boehringer Ingelheim International GmbH v Commissioner of Patents [2001] FCA 647 and Prejay Holdings Ltd v Commissioner of Patents [2003] FCAFC 77 applied. [read post]
9 Aug 2009, 4:54 pm
Boehringer Ingelheim Pharma GmbH & Co. [read post]